肠道微生物群：心血管疾病的一个环境风险因素。 - Suppr

Suppr

超能文献

Gut microbiota: an environmental risk factor for cardiovascular disease.

作者信息

Stock Jane

机构信息

Kronhusgatan 11, SE-411 05 Gothenburg, Sweden.

出版信息

Atherosclerosis. 2013 Aug;229(2):440-2. doi: 10.1016/j.atherosclerosis.2013.05.019. Epub 2013 May 25.

DOI:10.1016/j.atherosclerosis.2013.05.019

PMID:23880200

Abstract

摘要

相似文献

Gut microbiota: an environmental risk factor for cardiovascular disease.

Atherosclerosis. 2013 Aug;229(2):440-2. doi: 10.1016/j.atherosclerosis.2013.05.019. Epub 2013 May 25.

Gut flora metabolism of phosphatidylcholine promotes cardiovascular disease.

Nature. 2011 Apr 7;472(7341):57-63. doi: 10.1038/nature09922.

Gut microbiota metabolism of L-carnitine and cardiovascular risk.

Atherosclerosis. 2013 Dec;231(2):456-61. doi: 10.1016/j.atherosclerosis.2013.10.013. Epub 2013 Oct 24.

Major Increase in Microbiota-Dependent Proatherogenic Metabolite TMAO One Year After Bariatric Surgery.

Metab Syndr Relat Disord. 2016 May;14(4):197-201. doi: 10.1089/met.2015.0120. Epub 2016 Jan 26.

Dietary modification of the microbiome affects risk for cardiovascular disease.

Rejuvenation Res. 2013 Jun;16(3):241-4. doi: 10.1089/rej.2013.1447.

Listening to Our Gut: Contribution of Gut Microbiota and Cardiovascular Risk in Diabetes Pathogenesis.

Curr Diab Rep. 2015 Sep;15(9):63. doi: 10.1007/s11892-015-0634-1.

The Role of Microbiota in Cardiovascular Risk: Focus on Trimethylamine Oxide.

Curr Probl Cardiol. 2019 Jun;44(6):182-196. doi: 10.1016/j.cpcardiol.2018.06.005. Epub 2018 Jul 7.

Microbiome, trimethylamine N-oxide, and cardiometabolic disease.

Transl Res. 2017 Jan;179:108-115. doi: 10.1016/j.trsl.2016.07.007. Epub 2016 Jul 18.

Intestinal microbiota produced trimethylamine-N-oxide can increase the risk of cardiovascular disease.

J Pak Med Assoc. 2014 Apr;64(4):488.

Gut microbiota metabolites as integral mediators in cardiovascular diseases (Review).

Int J Mol Med. 2020 Sep;46(3):936-948. doi: 10.3892/ijmm.2020.4674. Epub 2020 Jul 13.

引用本文的文献

Microbiota in Gut-Heart Axis: Metabolites and Mechanisms in Cardiovascular Disease.

Compr Physiol. 2025 Jun;15(3):e70024. doi: 10.1002/cph4.70024.

How Different Are the Influences of Mediterranean and Japanese Diets on the Gut Microbiome?

Endocr Metab Immune Disord Drug Targets. 2024;24(15):1733-1745. doi: 10.2174/0118715303261069231124092259.

Deleterious Effect of Air Pollution on Human Microbial Community and Bacterial Flora: A Short Review.

Int J Environ Res Public Health. 2022 Nov 22;19(23):15494. doi: 10.3390/ijerph192315494.

Beneficial Effects of Essential Oils from the Mediterranean Diet on Gut Microbiota and Their Metabolites in Ischemic Heart Disease and Type-2 Diabetes Mellitus.

Nutrients. 2022 Nov 3;14(21):4650. doi: 10.3390/nu14214650.

TMAO Upregulates Members of the miR-17/92 Cluster and Impacts Targets Associated with Atherosclerosis.

Int J Mol Sci. 2022 Oct 11;23(20):12107. doi: 10.3390/ijms232012107.

Microbiome and Gestational Diabetes: Interactions with Pregnancy Outcome and Long-Term Infant Health.

J Diabetes Res. 2021 Nov 25;2021:9994734. doi: 10.1155/2021/9994734. eCollection 2021.

Trimethylamine -Oxide (TMAO) Modulates the Expression of Cardiovascular Disease-Related microRNAs and Their Targets.

Int J Mol Sci. 2021 Oct 15;22(20):11145. doi: 10.3390/ijms222011145.

Bacterial metabolites and cardiovascular risk in children with chronic kidney disease.

Mol Cell Pediatr. 2021 Oct 22;8(1):17. doi: 10.1186/s40348-021-00126-8.

Cardioprotective Effects of Taurisolo® in Cardiomyoblast H9c2 Cells under High-Glucose and Trimethylamine N-Oxide Treatment Sphingolipid Synthesis.

Oxid Med Cell Longev. 2020 Nov 12;2020:2961406. doi: 10.1155/2020/2961406. eCollection 2020.

Machine Learning Strategy for Gut Microbiome-Based Diagnostic Screening of Cardiovascular Disease.

Hypertension. 2020 Nov;76(5):1555-1562. doi: 10.1161/HYPERTENSIONAHA.120.15885. Epub 2020 Sep 10.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验